← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2022Last known activity
Jan 31, 2025
Timeline
2010s
- Jun 1, 2018
Kyverna Therapeutics— Founded
Drugs by trial phase (6 distinct, 10 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (15)
- NCT06590545CollaboratorPhase 1/Phase 2Jan 31, 2025
- NCT06475495CollaboratorPhase 1/Phase 2Nov 30, 2024
- NCT06384976Lead sponsorPhase 2Sep 30, 2024
- NCT06384976OfficialPhase 2Sep 30, 2024
- NCT06193889Lead sponsorPhase 2Aug 28, 2024
- NCT06193889OfficialPhase 2Aug 28, 2024
- NCT06400303OfficialPhase 1/Phase 2Aug 6, 2024
- NCT06400303Lead sponsorPhase 1/Phase 2Aug 6, 2024
- NCT06451159CollaboratorPhase 1Jun 30, 2024
- NCT06152172CollaboratorPhase 1Feb 29, 2024
- NCT06138132CollaboratorPhase 1Dec 31, 2023
- NCT05938725Lead sponsorPhase 1Apr 28, 2023
- NCT05938725Study directorPhase 1Apr 28, 2023
- NCT06342960OfficialPhase 1/Phase 2Dec 1, 2022
- NCT06342960Lead sponsorPhase 1/Phase 2Dec 1, 2022
Details
- Founded
- Emeryville, CA, US Jun 1, 2018
- Last known activity
- Jan 31, 2025